Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Alembic

    Tag: Alembic

    You Searched For "Alembic"
    Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

    Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

    Medical Dialogues Bureau18 March 2020 12:00 PM IST
    Gujrat: Alembic Pharmaceuticals Limited has announced that it has received Establishment Inspection Report (EIR) from US Food and Drug Administration...
    Alembic Pharma gets 4 observations from USFDA for Panelav facility

    Alembic Pharma gets 4 observations from USFDA for Panelav facility

    Medical Dialogues Bureau17 March 2020 10:57 AM IST
    Gujarat: Alembic Pharmaceuticals has announced that the US Food and Drug Administration (USFDA) has conducted an inspection at Alembic...
    Alembic  Pharma bags USFDA nod for doxycycline hyclate tablets

    Alembic Pharma bags USFDA nod for doxycycline hyclate tablets

    MD bureau6 March 2020 9:15 AM IST
    Doxycycline hyclate tablets 20 mg have an estimated market size of USD 7 million for the 12-month period ending December 2019
    Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets

    Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets

    Medical Dialogues Bureau29 Jan 2020 1:25 PM IST
    Alembic Pharmaceuticals announces USFDA Final Approval for Azithromycin Tablets USP, 600 mg. Alembic Pharmaceuticals Limited (Alembic) has announced...
    Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

    Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

    Farhat Nasim25 Jun 2019 11:54 AM IST
    The approved product, Oseltamivir Phosphate capsule is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La...
    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Farhat Nasim15 April 2019 10:05 AM IST
    Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Farhat Nasim6 March 2019 9:45 AM IST
    The company's JV, Aleor Dermaceuticals Ltd, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug...
    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Farhat Nasim21 Feb 2019 9:45 AM IST
    Acetazolamide extended-release capsule is therapeutically equivalent to the reference listed drug, Diamox Sequels, 500 mg, of Teva Branded...
    SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination

    SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination

    Ruby Khatun Khatun16 Dec 2017 3:40 PM IST
    New Delhi: The Supreme Court referred 344 fixed dose combination (FDC) medicines, including well- known brands like Corex cough syrup, Vicks Action...
    Delhi HC allows Natco, Alembic to Export Rivaroxaban of Bayer

    Delhi HC allows Natco, Alembic to Export Rivaroxaban of Bayer

    savita thakur thakur10 March 2017 9:45 AM IST
    NEW DELHI: In a recent order passed by Delhi High Court, the court has granted the permission to Indian pharmaceuticals companies, Alembic and Natco...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok